Despite modern medical interventions, infectious diseases continue to generate huge socio-economic losses. The benefits of eradicating a disease are therefore high. While successful with smallpox and rinderpest, many other eradication attempts have failed. Eradications require huge and costly efforts, which can be sustained only if sufficient progress can be achieved. While initial successes are usually obtained more easily, progress often becomes harder as a disease becomes rare in the eradication endgame. A long eradication tail of slowly decreasing incidence levels can frustrate eradication efforts, as it becomes unclear whether progress toward eradication is still being made and how much more needs to be invested to push the targeted disease beyond its extinction threshold. Realistic disease dynamics are complicated by evolutionary responses to interventions and by interactions among different temporal and spatial scales. Models accounting for these complexities are required for understanding the shapes of eradication tails. In particular, such models allow predicting how hard or costly eradication will be, and may even inform in which manner progress has to be assessed during the eradication endgame. Here we outline a general procedure by analyzing the eradication tails of generic SIS diseases, taking into account two major ingredients of realistic complexity: a group-structured host population in which host contacts within groups are more likely than host contacts between groups, and virulence evolution subject to a trade-off between host infectivity within groups and host mobility among groups. Disentangling the epidemiological, evolutionary, and economic determinants of eradication tails, we show how tails of different shapes arise depending on salient model parameters and on how the extinction threshold is approached. We find that disease evolution generally extends the eradication tail and show how the cost structure of eradication measures plays a key role in shaping eradication tails.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jtbi.2016.03.019 | DOI Listing |
Biochem Biophys Res Commun
December 2024
Department of Biomedical Engineering, University of Kentucky, USA. Electronic address:
Extracellular vesicles (EVs) such as microparticles secreted by the cells can be manipulated and used for delivering therapeutic drugs to target and eradicate cancer cells. However, high encapsulation efficiency and mass production of the microparticles remain difficult to achieve. Efficient and targeted delivery to cancer cells is another hurdle to be addressed.
View Article and Find Full Text PDFMater Horiz
November 2024
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
The supramolecular chemistry of small chiral molecules has attracted widespread attention owing to their similarity to natural assembly codes. Two-component low-molecular-weight (LMW) hydrogels are crucial as they form helical structures chirality transfer, enabling diverse functions. Herein, we report a pair of two-component chiral LMW hydrogels based on the small molecular drugs baicalin (BA), scutellarin (SCU) and berberine (BBR).
View Article and Find Full Text PDFmBio
November 2024
Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
The current treatments for toxoplasmosis are only active against fast-growing tachyzoites, present in acute infections, with little effect on slow-growing bradyzoites within tissue cysts, present in latent chronic infections. The mitochondrion of is essential for its survival, and one of the major anti-parasitic drugs, atovaquone, inhibits the mitochondrial electron transport chain at the coenzyme Q:cytochrome c oxidoreductase site. Coenzyme Q (also known as ubiquinone [UQ]) consists of a quinone head and a lipophilic, isoprenoid tail that anchors UQ to membranes.
View Article and Find Full Text PDFActa Biomater
November 2024
School of Biomedical Engineering, State Key Laboratory of Marine Resource Utilization in South China Sea, Hainan University, Haikou 570228, PR China; Key Laboratory of Biomedical Engineering of Hainan Province, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, PR China. Electronic address:
The rise of multidrug-resistant bacteria (MDRB) has made bacterial infection one of the biggest health threats, causing numerous antibiotics to fail. Real-time monitoring of bacterial disease treatment efficacy at the infection site is required. Herein, we report a versatile Raman tag 3,3'-diethylthiatricarbocyanine iodide (DTTC)-conjugated star-shaped Au-MoS@hyaluronic acid (AMD@HA) nanocomposite as a surface-enhanced Raman scattering (SERS) nanoprobe for quick bacterial identification and in-situ eradication.
View Article and Find Full Text PDFACS Appl Mater Interfaces
September 2024
Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!